Meet the One Million Strong – Cheryl A. from Maryland

Meet Cheryl Cheryl Alston, survivor White Plains, MD Cheryl’s Story In 2007, I turned 50 years old and my doctor suggested I have a colonoscopy. My doctor referred me, but I “lost” the referral and did not seek another. About two years later, in 2009, my…

Read Full Post

My Experience with Oral Chemotherapy

by Pam Seijo, advocate & stage IV survivor Back in the early 2000’s, after 21 months of chemo, radiation and surgeries, my body was struggling with blood counts, nutrition and overall existence. My oncologist and surgeon wanted me on chemo, but Irinotecan was doing me…

Read Full Post

Generic Xeloda Now Available

Last week, the Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat metastatic colorectal cancer. Kathleen Uhl, M.D., acting director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and…

Read Full Post

Avastin with XELIRI or FOLFIRI: Is There Any Difference?

When Avastin is added to the combination of Xeloda and irinotecan as an initial treatment for advanced colorectal cancer, the treatment is equally effective as Avastin with FOLFIRI. But side effects are more difficult. After a randomized clinical trial comparing Avastin with XELIRI (Xeloda, irinotecan)…

Read Full Post

Hand-Foot Syndrome Signals Xeloda Effectiveness

Developing tender swelling or rash on their hands and feet may actually be good news for patients being treated with Xeloda® (capecitabine). During a recent clinical trial, colorectal cancer patients with hand-foot syndrome lived longer, and it took longer for their cancer to get worse….

Read Full Post

Avastin Helps Patients Maintain Chemotherapy Effectiveness

It doesn’t hurt to stop XELOX chemotherapy combined with Avastin after six treatments and continue with Avastin alone until colorectal cancer gets worse, according to a study reported at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago. Many patients have…

Read Full Post

Older patients benefit from XELOX after surgery

Update from 2010 GI Cancers Symposium Colon cancer patients over 70 actually had a greater reduction in disease-free survival than did younger ones with a new regimen of Xeloda® and oxaliplatin compared to older IV 5-FU treatments according to a new analysis reported at the…

Read Full Post

XELOX Beats 5-FU with Fewer Recurrences

A combination of Xeloda and Eloxatin (XELOX) was better than standard 5-FU and leucovorin chemotherapy in reducing recurrences of stage III colon cancer after surgery.  Significantly more patients receiving XELOX were alive without cancer three years after treatment began. Roche announced results of a Phase…

Read Full Post

Comparing 5-FU or Capecitabine Combined with Oxaliplatin

Infusional 5-FU or oral Xeloda® (capecitabine) are two different drugs that can be combined with Eloxatin® (oxaliplatin) to treat colorectal cancer that has spread.  Six different randomized clinical trials have compared the two approaches. Researchers analyzed a pool of all six trials to find out…

Read Full Post
Page 1 of 212